InsidersTradesSigma
아스테라시스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 아스테라시스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 아스테라시스 has published 32 insider filings. Market capitalisation: €214.9bn. The latest transaction was filed on 16 July 2026 (Sale). Among the most active insiders: 서은택. All data is openly available.
32
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,194 of 27,732 companies
67.7
score / 100
Value47
Quality89
FCF yld1.7%
Earn yld4.4%
EV/EBITDA16.6x
ROE19%
Gross mgn79%
Net mgn24%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations32 total
25 of 32 declarations
About 아스테라시스
Asterasis is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.